Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Elisabeth Smits
PHARMO Institute for Drug Outcomes Research, the Netherlands, Netherlands
Poster(s):
(8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
Sunday, August 28, 2022
8:00 AM – 1:45 PM
CEST
(142) Validation of Safety Outcomes in Routinely Collected Data: Lessons Learned from a Multinational Post-Approval Safety Study
Sunday, August 28, 2022
8:00 AM – 1:45 PM
CEST
